trial · primary record
Paclitaxel
Germ Cell Cancer Metastatic
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2029-10 |
| Primary endpoint | 1-year progression-free survival (PFS) |
| Registry ID | NCT07847190 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:45.049Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07847190
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.